<VariationArchive VariationID="475488" VariationName="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs)" VariationType="Deletion" Accession="VCV000475488" Version="11" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2017-12-26" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="451621" VariationID="475488">
      <GeneList>
        <Gene Symbol="SLC6A1" FullName="solute carrier family 6 member 1" GeneID="6529" HGNC_ID="HGNC:11042" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10992748" stop="11039247" display_start="10992748" display_stop="11039247" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11034419" stop="11080934" display_start="11034419" display_stop="11080934" Strand="+" />
          </Location>
          <OMIM>137165</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs)</Name>
      <CanonicalSPDI>NC_000003.12:11022384:CGCTGGCCACTGGCCATCACGCTGGCCA:CGCTGGCCA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="11022385" stop="11022403" display_start="11022385" display_stop="11022403" variantLength="19" positionVCF="11022384" referenceAlleleVCF="CCGCTGGCCACTGGCCATCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11064071" stop="11064089" display_start="11064071" display_stop="11064089" variantLength="19" positionVCF="11064070" referenceAlleleVCF="CCGCTGGCCACTGGCCATCA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L36fs</ProteinChange>
      <ProteinChange>L94fs</ProteinChange>
      <ProteinChange>L214fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.11064080_11064098del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.11064080_11064098del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.11022394_11022412del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.11022394_11022412del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053003.1" sequenceAccession="NG_053003" sequenceVersion="1" change="g.34666_34684del">
            <Expression>NG_053003.1:g.34666_34684del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348250.2" sequenceAccession="NM_001348250" sequenceVersion="2" change="c.640_658del">
            <Expression>NM_001348250.2:c.640_658del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335179.1" sequenceAccession="NP_001335179" sequenceVersion="1" change="p.Leu214fs">
            <Expression>NP_001335179.1:p.Leu214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348251.2" sequenceAccession="NM_001348251" sequenceVersion="2" change="c.280_298del">
            <Expression>NM_001348251.2:c.280_298del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335180.1" sequenceAccession="NP_001335180" sequenceVersion="1" change="p.Leu94fs">
            <Expression>NP_001335180.1:p.Leu94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348252.2" sequenceAccession="NM_001348252" sequenceVersion="2" change="c.106_124del">
            <Expression>NM_001348252.2:c.106_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335181.1" sequenceAccession="NP_001335181" sequenceVersion="1" change="p.Leu36fs">
            <Expression>NP_001335181.1:p.Leu36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348253.2" sequenceAccession="NM_001348253" sequenceVersion="2" change="c.106_124del">
            <Expression>NM_001348253.2:c.106_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335182.1" sequenceAccession="NP_001335182" sequenceVersion="1" change="p.Leu36fs">
            <Expression>NP_001335182.1:p.Leu36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003042.4" sequenceAccession="NM_003042" sequenceVersion="4" change="c.640_658del" MANESelect="true">
            <Expression>NM_003042.4:c.640_658del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003033.3" sequenceAccession="NP_003033" sequenceVersion="3" change="p.Leu214fs">
            <Expression>NP_003033.3:p.Leu214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003042.3" sequenceAccession="NM_003042" sequenceVersion="3" change="c.640_658delCTGGCCATCACGCTGGCCA">
            <Expression>NM_003042.3:c.640_658delCTGGCCATCACGCTGGCCA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658657269" DB="ClinGen" />
        <XRef Type="rs" ID="1553688970" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs) AND not provided" Accession="RCV000599614" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs) AND Inborn genetic diseases" Accession="RCV002358609" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs) AND SLC6A1-related neurodevelopmental disorder" Accession="RCV002464258" Version="1">
        <ClassifiedConditionList TraitSetID="81252">
          <ClassifiedCondition>SLC6A1-related neurodevelopmental disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs) AND Myoclonic-astatic epilepsy" Accession="RCV003444594" Version="1">
        <ClassifiedConditionList TraitSetID="72209">
          <ClassifiedCondition DB="MedGen" ID="C0393702">Myoclonic-astatic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs) AND Myoclonic-atonic epilepsy" Accession="RCV003762798" Version="1">
        <ClassifiedConditionList TraitSetID="92306">
          <ClassifiedCondition DB="MedGen" ID="CN231318">Myoclonic-atonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-16" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-12-26" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25865495</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="81252" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="66348" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">SLC6A1-related neurodevelopmental disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="72209" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="29076" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic-astatic epilepsy</ElementValue>
                <XRef ID="MONDO:0016025" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Generalized myoclonic-atonic seizure</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic atonic seizures</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2169" />
                <XRef ID="2169" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="C0393702" DB="MedGen" />
              <XRef ID="MONDO:0016025" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011170" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="92306" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33535" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic-atonic epilepsy</ElementValue>
                <XRef ID="MONDO:0014633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAE</ElementValue>
                <XRef Type="MIM" ID="616421" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16108" />
                <XRef ID="16108" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36780407</ID>
                <ID Source="BookShelf">NBK589173</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="CN231318" DB="MedGen" />
              <XRef ID="MONDO:0014633" DB="MONDO" />
              <XRef Type="MIM" ID="616421" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390416" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1896679|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710410" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.640_658del19 variant in the SLC6A1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.640_658del19 variant causes a frameshift starting with codon Leucine 214, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 32 of the new reading frame, denoted p.Leu214SerfsX32. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Furthermore, the c.640_658del19 variant is not observed in large population cohorts (Lek et al., 2016). The presence of the c.640_658del19 pathogenic variant is consistent with the diagnosis of an SLC6A1-related disorder in this individual.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003042.3:c.640_658del19</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2242117" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000003.11:g.11064071_11064089delCGCTGGCCACTGGCCATCA|OMIM:616421" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001136318" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.11064071_11064089delCGCTGGCCACTGGCCATCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616421" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5399135" SubmissionDate="2022-12-06" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="genomeconnect_27353_622|SLC6A1-related neurodevelopmental disorder" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002760013" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="GenomeConnect - Brain Gene Registry" OrgID="508359" OrganizationCategory="patient registry" OrgAbbreviation="GenomeConnect - BGR" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Likely pathogenic and reported on 03-22-2021 by Lab or GTR ID Children's Hospital of Philadelphia. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Exome Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2021-03-22" integerValue="165021">Genomic Diagnostic Laboratory, Division of Genomic Diagnostics,Children's Hospital of Philadelphia</Attribute>
                <Comment>Likely pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <Method>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2021-03-22" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000729" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012758" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003042.4:c.640_658del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SLC6A1-related neurodevelopmental disorder</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BGR - 12.22 - hg19</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1253915" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1976734|MedGen:C4085238" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000655706" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25865495</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu214Serfs*32) in the SLC6A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC6A1 are known to be pathogenic (PMID: 25865495). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC6A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 475488). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.11064071_11064089del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4085238" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5145111" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a420316|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002655630" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.640_658del19 pathogenic mutation, located in coding exon 5 of the SLC6A1 gene, results from a deletion of 19 nucleotides at nucleotide positions 640 to 658, causing a translational frameshift with a predicted alternate stop codon (p.L214Sfs*32). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003042.3:c.640_658del19</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1390416" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5399135" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012758" MappingRef="HP">
        <MedGen CUI="C4022738" Name="Neurodevelopmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5399135" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000729" MappingRef="HP">
        <MedGen CUI="C0856975" Name="Autistic behavior" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2242117" TraitType="Disease" MappingType="XRef" MappingValue="616421" MappingRef="OMIM">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1253915" TraitType="Disease" MappingType="XRef" MappingValue="C4085238" MappingRef="MedGen">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5399135" TraitType="Disease" MappingType="Name" MappingValue="SLC6A1-related neurodevelopmental disorder" MappingRef="Preferred">
        <MedGen CUI="None" Name="SLC6A1-related neurodevelopmental disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5145111" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

